NIS - libdoc.who.int - World Health Organization

More documents

Recommendations

Info

WHO monographs on medicinal plants commonly used in the Newly Independent States (<strong>NIS</strong>) 66. Abdul-Ghani AS et al. Hypotensive effect of Crataegus oxyacantha. International Journal of Crude Drug Research, 1987, 25:216–220. 67. Fehri B et al. Valeriana officinalis et Crataegus oxyacantha toxicité par administrations réitérées et investigations pharmacologiques. Journale de Pharmacie de Belgique, 1991, 46:165–176. 68. Liévre M et al. Étude des effets cardiovasculaires de l’hyperoside extrait de l’Aubépine chez le chien anesthésié. Annales pharmaceutiques françaises, 1985, 5:471–477. 69. Rácz-Kotilla E et al. Hypotensive and beta-blocking effect of procyanidins of Crataegus monogyna. Planta Medica, 1980, 39:239. 70. Bahorun T et al. Antioxidant activities of Crataegus monogyna extracts. Planta Medica, 1994, 60:323–328. 71. Bahorun T et al. Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittel-Forschung, 1996, 46:1086–1089. 72. Rakotoarison DA et al. Antioxidant activities of polyphenolic extracts from flowers, in vitro callus and cell suspension culture of Crataegus monogyna. Pharmazie, 1997, 52:60–64. 73. Petkov E et al. Inhibitory effect of some flavonoids and flavonoid mixtures on cyclic AMP phosphodiesterase activity of rat heart. Planta Medica, 1981, 43:183–186. 74. Schüssler M et al. Comparison of the flavonoids occurring in Crataegus species and inhibition of 3’,5’-cyclic adenosine monophosphate phosphodiesterase. Planta Medica, 1991, 57 (Suppl. 2):A133. 75. Schüssler M et al. Cardiac effects of flavonoids from Crataegus species. Planta Medica, 1993, 59 (Suppl. 2):A688. 76. Vibes J et al. Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (hawthorn) flower heads. Prostaglandins, Leukotrienes and Essential Fatty Acids, 1994, 50:173–175. 77. Vibes J et al. Effects of a methanolic extract from Crataegus oxyacantha blossoms on TXA 2 and PGI 2 synthesising activities of cardiac tissue. Medical Science Research, 1993, 21:435–436. 78. Wrocinski T. Determination of the activity of spasmolytic drugs with reference to the papaverine standard. Biuletyn Instytutu Roslin Lecznniczych, 1960, 6:236. 79. Beretz A et al. Choix de méthodes pharmacologiques pour l’étude des activités de l’aubépine. Plantes médicinales et Phytothérapie, 1978, 12:305–314. 80. Della Loggia R et al. Depressive effect of Crataegus oxyacantha L. on central nervous system in mice. Science and Pharmacy, 1983, 51:319–324. 81. Borkowski B. Diuretic action of several flavone drugs. Planta Medica, 1960, 8:95–104. 82. Schlegelmilch R, Heywood R. Toxicity of Crataegus (hawthorne) extract (WS 1442). Journal of the American College of Toxicology, 1994, 13:103–111. 110
Folium cum Flore Crataegi 83. Hecker-Niediek AE. Untersuchungen zur Biogenese, Markierung und Pharmakokinetik der Procyanidine aus Crataegus-Species [Dissertation]. Marburg, University of Marburg, 1983. 84. Blumenthal M et al., eds. The complete German Commission E monographs. Austin, TX, American Botanical Council, 1998. 85. Schimmer O et al. The mutagenic potencies of plant extracts containing quercetin in Salmonella typhimurium TA98 and TA100. Mutation Research, 1988, 206:201–208. 86. Albrecht A, Juretzek W. Weissdorn (Crataegus laevigata, Crataegus monogyna), Weissdornblätter mit Blüten (Crataegi folium cum flore). Berlin, Springer: Loseblatt System Naturheilverfahren, 1995. 111
Page 1:
WHO monographs on medicinal plants
Page 4 and 5:
WHO Library Cataloguing-in-Publicat
Page 6 and 7:
Contents Herba Thymi 383 Flos Tilia
Page 9 and 10:
Introduction Background The results
Page 11 and 12:
Introduction monographs on herbal m
Page 13 and 14:
General technical notices These WHO
Page 15:
General technical notices The Exper
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 45 and 46:
Herba Bidentis Definition Herba Bid
Page 47 and 48:
Herba Bidentis multicellular with a
Page 49 and 50:
Herba Bidentis Chemical assays Cont
Page 51 and 52:
Herba Bidentis ity in vivo against
Page 53 and 54:
Herba Bidentis References 1. USSR p
Page 55:
Herba Bidentis 42. Kortikov VN, Kor
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 69 and 70: Flos Chamomillae * Definition Flos
Page 71 and 72: Flos Chamomillae Geographical distr
Page 73 and 74: Flos Chamomillae Dosage forms Dried
Page 75 and 76: Flos Chamomillae Intradermal applic
Page 77 and 78: Flos Chamomillae able directly thro
Page 79: Flos Chamomillae steroidalen (5% Bu
Page 82 and 83: WHO monographs on medicinal plants
Page 99 and 100: Folium cum Flore Crataegi * Definit
Page 101 and 102: Folium cum Flore Crataegi the cells
Page 103 and 104: Folium cum Flore Crataegi noid deri
Page 105 and 106: Folium cum Flore Crataegi pr o c y
Page 107 and 108: Folium cum Flore Crataegi arrhythmi
Page 109 and 110: Folium cum Flore Crataegi tract (co
Page 111 and 112: Folium cum Flore Crataegi extract a
Page 113 and 114: Folium cum Flore Crataegi metabolic
Page 115 and 116: Folium cum Flore Crataegi 21. Ficar
Page 117: Folium cum Flore Crataegi trique et
Page 169 and 170:
Radix Glycyrrhizae * Definition Rad
Page 171 and 172:
Radix Glycyrrhizae Glycyrrhiza ural
Page 173 and 174:
Radix Glycyrrhizae Dilute alcohol-s
Page 175 and 176:
Radix Glycyrrhizae Uses described i
Page 177 and 178:
Radix Glycyrrhizae Contraindication
Page 179 and 180:
Radix Glycyrrhizae 13. Chin WY, Ken
Page 181:
Radix Glycyrrhizae 46. Rask-Madsen
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 195 and 196:
Fructus Hippophaës recens Definiti
Page 197 and 198:
Fructus Hippophaës recens mis has
Page 199 and 200:
Fructus Hippophaës recens extracti
Page 201 and 202:
Fructus Hippophaës recens diation
Page 203 and 204:
Fructus Hippophaës recens rocytes
Page 205 and 206:
Fructus Hippophaës recens For inte
Page 207 and 208:
Fructus Hippophaës recens 40. Yue
Page 209 and 210:
Herba Hyperici * Definition Herba H
Page 211 and 212:
Herba Hyperici beaded. Dorsoventral
Page 213 and 214:
Herba Hyperici Major chemical const
Page 215 and 216:
Herba Hyperici Uses reported in pha
Page 217 and 218:
Herba Hyperici An ethanol extract o
Page 219 and 220:
Herba Hyperici Effect on smooth mus
Page 221 and 222:
Herba Hyperici hypericin) daily for
Page 223 and 224:
Herba Hyperici tract of the herb fo
Page 225 and 226:
Herba Hyperici 24.8-26.5 hours and
Page 227 and 228:
Herba Hyperici trations, leading to
Page 229 and 230:
Herba Hyperici 9. British herbal ph
Page 231 and 232:
Herba Hyperici mische und klinische
Page 233 and 234:
Herba Hyperici 77. Wood S et al. An
Page 235:
Herba Hyperici 111. Konig CD. Hyper
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 293 and 294:
Herba Origani Definition Herba Orig
Page 295 and 296:
Herba Origani rolla-like, glabrous
Page 297 and 298:
Herba Origani Heavy metals For maxi
Page 299 and 300:
Herba Origani essential oil of the
Page 301 and 302:
Herba Origani Contraindications If
Page 303 and 304:
Herba Origani 24. Muravjova DA, Sam
Page 305 and 306:
Herba Origani 60. Oka Y et al. Nema
Page 307 and 308:
Herba Pegani harmalae Definition He
Page 309 and 310:
Herba Pegani harmalae contain mucil
Page 311 and 312:
Herba Pegani harmalae dominate. Oth
Page 313 and 314:
Herba Pegani harmalae ously and 2 m
Page 315 and 316:
Herba Pegani harmalae Adverse react
Page 317 and 318:
Herba Pegani harmalae 21. Pakalns D
Page 319:
Herba Pegani harmalae 60. Al-Shamma
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
342
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 371 and 372:
Folium Sennae * Definition Folium S
Page 373 and 374:
Folium Sennae 10 4 /g. Preparations
Page 375 and 376:
Folium Sennae Medicinal uses Uses s
Page 377 and 378:
Folium Sennae induce hypokalaemia,
Page 379 and 380:
Folium Sennae 19. Guidelines for pr
Page 381 and 382:
Radix cum Herba Taraxaci * Definiti
Page 383 and 384:
Radix cum Herba Taraxaci General id
Page 385 and 386:
Radix cum Herba Taraxaci Pharmacolo
Page 387 and 388:
Radix cum Herba Taraxaci intraperit
Page 389 and 390:
Radix cum Herba Taraxaci 13. Qualit
Page 391 and 392:
Herba Thymi * Definition Herba Thym
Page 393 and 394:
Herba Thymi General identity tests
Page 395 and 396:
Herba Thymi Uses described in pharm
Page 397 and 398:
Herba Thymi Nursing mothers See Pre
Page 399:
Herba Thymi 29. Juven BJ, Kanner J,
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Page 412 and 413:
Page 414 and 415:
Page 416 and 417:
Page 418 and 419:
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 431 and 432:
Styli cum stigmatis Zeae maydis Def
Page 433 and 434:
Styli cum stigmatis Zeae maydis Mic
Page 435 and 436:
Styli cum stigmatis Zeae maydis bee
Page 437 and 438:
Styli cum stigmatis Zeae maydis min
Page 439 and 440:
Styli cum stigmatis Zeae maydis ous
Page 441 and 442:
Styli cum stigmatis Zeae maydis Nur
Page 443 and 444:
Styli cum stigmatis Zeae maydis 37.
Page 445:
Styli cum stigmatis Zeae maydis 73.
Page 448 and 449:
Page 450 and 451:
442
Page 452:
Despite the increasing use of herba
show all

NIS - libdoc.who.int - World Health Organization

Create successful ePaper yourself

Delete template?

Save as template?